All the news Showing 10 of 56 articles from: Treatment outcomesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Liver fibrosis improves after successful treatment for hepatitis C Liz Highleyman / 23 November 2015 A majority of people with chronic hepatitis C and advanced fibrosis or cirrhosis showed improvement in liver health following treatment, according to study findings presented last week at the 2015 AASLD Liver ... Liver cancer risk will remain elevated for people with cirrhosis cured of hepatitis C Keith Alcorn / 16 November 2015 The burden of liver cancer and cirrhosis caused by hepatitis C is likely to continue to grow in the United States despite curative treatment for hepatitis C, and people who have cirrhosis ... Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection Liz Highleyman / 06 August 2015 People with HIV and HCV co-infection, with liver cirrhosis, who achieve sustained virological response (SVR) and experience an improvement in liver fibrosis are less likely to develop liver disease complications or die from ... Liver function and survival improve after treatment with Viekirax + Exviera regimen Liz Highleyman / 27 June 2015 People with hepatitis C who were treated with AbbVie's Viekirax plus Exviera or '3D' regimen saw improvements in liver function biomarkers, had better quality of life and had increased survival compared to ... HCV viral load levels during treatment and speed of decline do not predict cure with interferon-free therapy Liz Highleyman / 23 April 2015 Direct-acting antiviral regimens containing sofosbuvir (Sovaldi) and the drugs in Viekirax/Exviera were highly effective regardless of how soon hepatitis C viral load became undetectable after starting treatment, according to research presented at the recent ... Re-infection due to ongoing risk probably the cause of HCV recurrence after SVR Michael Carter / 18 March 2015 Rates of hepatitis C virus (HCV) reoccurrence after successful therapy differ markedly between risk groups, according to the results of a meta-analysis presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI ... Sustained virological response represents a long-term cure for people with hepatitis C treated with sofosbuvir Liz Highleyman / 18 March 2015 Almost all patients with hepatitis C virus alone or HIV/HCV co-infection who achieved sustained virological response (SVR) to treatment with sofosbuvir (Sovaldi) plus ribavirin or sofosbuvir/ledipasvir (Harvoni) still had undetectable HCV RNA ... Sustained virological response to hepatitis C treatment reduces mortality, liver cancer and liver transplants Liz Highleyman / 10 November 2014 People who achieve sustained virological response (SVR) when treated with interferon-based therapy for hepatitis C have a lower risk of death, are less likely to develop liver cancer and need fewer liver transplants ... Successful hepatitis C treatment reduces risk of liver cancer and death, but most remain untreated Liz Highleyman / 19 November 2013 Hepatitis C treatment that leads to viral cure significantly reduces the likelihood of liver disease progression and liver-related mortality, but most people with hepatitis C remain untreated, according to a presentation at The Liver ... Interferon response reduces liver disease and death in people with HIV/HCV co-infection Liz Highleyman / 19 September 2013 Effective interferon-based therapy that produces sustained virological response led to significant reductions in liver decompensation, HIV disease progression and both overall and liver-related mortality among people with HIV and hepatitis C co-infection, according ... ← Prev1...23456Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive